The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


RENAGEL

800 Milligram Tablets

Genzyme Europe B.V.EU/1/99/123/011

Main Information

Trade NameRENAGEL
Active SubstancesSEVELAMER
Strength800 Milligram
Dosage FormTablets
Licence HolderGenzyme Europe B.V.
Licence NumberEU/1/99/123/011

Group Information

ATC CodeV03AE02 sevelamer

Status

Authorised/WithdrawnAuthorised
Licence Issued23/04/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back